LENZ
LENZ Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.56
-0.20 (-3.47%)
Rating:B-
Company Profile
CEO
Evert Schimmelpennink
IPO Date
2024-03-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$5.75
Prev. Close
$5.76
Day Low
$5.53
Day High
$5.84
52W Low
$5.23
52W High
$50.40
Market Cap
$0.17B
Volume
0.16M